Live Breaking News & Updates on Flebogamma Immune Globulin Intravenous

Stay updated with breaking news from Flebogamma immune globulin intravenous. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Morgan Stanley Lowers Grifols (NASDAQ:GRFS) to Equal Weight

Morgan Stanley lowered shares of Grifols (NASDAQ:GRFS – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday morning, FlyOnTheWall reports. Separately, StockNews.com began coverage on Grifols in a research report on Thursday, August 17th. They set a hold rating for the company. Five investment analysts have rated […] ....

United States , Albutein Flexbag , Vistaseal Veraseal , Financial Services Group Inc , Morgan Stanley , Quadrant Capital Group , Grifols Company Profile , Free Report , Get Free Report , Financial Advisors , Capital Group , Services Group , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols, S.A. (NASDAQ:GRFS) Receives $10.58 Consensus Price Target from Brokerages

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) have earned an average rating of “Moderate Buy” from the six research firms that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 […] ....

United States , Vistaseal Veraseal , Albutein Flexbag , Grifols Company Profile , Goldman Sachs Group Inc , Wells Fargo Company , Orion Portfolio Solutions , Get Free Report , Marketbeat Ratings , Portfolio Solutions , Goldman Sachs Group , Sachs Group , Get Free , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of Grifols (NASDAQ:GRFS – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Morgan Stanley upgraded Grifols from an equal weight rating to an overweight rating in a research report on Wednesday, April 12th. Four equities research analysts have rated […] ....

United States , Nova Scotia , Albutein Flexbag , Vistaseal Veraseal , Us Bancorp , Morgan Stanley , Raymond James Associates , Blackrock Inc , Advisor Group Holdings Inc , Financial Services Group Inc , Grifols Company Profile , Free Report , Group Holdings , Services Group , Get Free Report , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs , Stocknews Com ,